Skip to main content

Advertisement

SpringerLink
Log in

A New Radiocolloid for Sentinel Node Detection in Breast Cancer

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background:The optimal radioactive tracer and technique for sentinel lymph node localization in breast cancer is yet to be determined. The dilemma of small particle size with dispersion to second echelon nodes versus failure of migration of larger radiocolloids needs to be resolved. A new radiocolloid preparation with particle size under 0.1 micron was developed with excellent primary/post lymphatic entrapment ratio.

Objective:To assess the feasibility of a new 99mTc radiocolloid cysteine-rhenium colloid in sentinel lymph node (SLN) localization for breast cancer.

Methods:Forty-seven patients with newly diagnosed T1 or T2 breast cancer underwent injection of 99mTc-labeled cysteine-rhenium colloid followed by lymphoscintigraphy. Same day SLN biopsy with patent blue dye and intraoperative gamma probe to identify SLNs were performed.

Results:SLN mapping and intraoperative localization were successful in 46/47 (98%) of patients. The blue dye radioactive tracer concordance was 94%. There was one false-negative in a patient with a nonpalpable tumor that underwent ultrasound-guided peritumoral radiocolloid injection.

Conclusions:99mTc-cysteine-rhenium colloid is highly effective in identifying SLNs. It has the advantage of smaller particle size than sulfur colloid with easier lymphatic migration. It has a more neutral pH with less pain on injection and does not require filtration, thereby minimizing radiation exposure to technologists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Hultborn KA, LarsonnL-G, Ragnhult I. The lymph drainage from the breast to the axillary and parasternal lymph nodes studied with the aid of colloidal Au 198. Acta Radiol 1955; 43: 52–63.

    Google Scholar 

  2. Weinberg J, Greaney EM. Identification of regional lymph nodes by means of vital staining dye during surgery of gastric cancer. Surg Gynecol Obstet 1950; 90: 561–7.

    CAS  PubMed  Google Scholar 

  3. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392–9.

    CAS  PubMed  Google Scholar 

  4. Alex JC, Krag DN. Gamma probe guided localization of lymph nodes. Surg Oncol 1993; 2: 137–43.

    Article  Google Scholar 

  5. Moffat FL,Jr; Gulec SA, Sittler SY, et al. Unfiltered sulfur colloid and sentinel node biopsy for breast cancer: technical and kinetic considerations Ann Surg Oncol 1999; 6: 746–55.

    Google Scholar 

  6. Bedrosion I, Scheff AM, Mick R, et al. 99m Tc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes. J Nucl Med 1999; 40: 7143–8.

    Google Scholar 

  7. Zabel PL, Dunn KE. Development of a smaller “in house” Tc-99m colloid for potential use in sentinel node lymphoscintigraphy, bone marrow scintigraphy and lung aerosol ventilation studies. Proceedings of the Annual Scientific Meeting of the Canadian Society of Nuclear Medicine, Alberta, Canada March 1999.

  8. Eschima D, Eschima L, Gotti N, et al. Technetium-99m sulfur colloid for lymphoscintigraphy; effects of preparation parameters. J Nucl Med 1996; 37: 1575–1578.

    Google Scholar 

  9. Package Insert Nanocis, CIS Bio International.

  10. Zabel PL, Dunn KE. Tc-99m rhenium colloid displays the highest primary lymph node entrapment when compared to 3 other Tc-99m colloids in a rabbit lymphoscintigraphy study. Proceedings of the Annual Scientific Meeting of the Canadian Society of Nuclear Medicine, Quebec April 1–4, 2000.

  11. Krag DN, Meijer SJ, Weaver DL, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335–9.

    Article  CAS  PubMed  Google Scholar 

  12. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391–8.

    PubMed  Google Scholar 

  13. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997; 349: 1864–7.

    Article  CAS  PubMed  Google Scholar 

  14. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 2345–50.

  15. Linehan DC, Hill AD, Akhurst T, Yeung H, et al. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients Ann Surg Oncol 1999; 6: 450–4.

    Google Scholar 

  16. Bembenek A, Schlag PM. Lymph-node dissection in breast cancer. Langenbecks Arch Surg 2000; 385: 236–45.

    Google Scholar 

  17. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998; 339: 941–6.

    Article  CAS  PubMed  Google Scholar 

  18. Krag DN, Aschikaga T, Harlow SP, Weaver DL. Development of sentinel node targeting technique in breast cancer patients. Br Journal 1998; 4: 67–74.

    Google Scholar 

  19. Nathanson SD, Anaya P, Karvelis KC, Eck L, Havstad S. Sentinel lymph node uptake of two different technetium-labeled radiocolloids. Ann Surg Oncol 1997; 4: 104–10.

    Google Scholar 

  20. Linehan DC, Hill AD, Tran KN, Yeung H, Yeh SD, Borgen PI, Cody HS III. Sentinel lymph node biopsy in breast cancer: unfiltered radioisotope is superior to filtered J Am Coll Surg 1999; 188: 377–81.

    Google Scholar 

  21. Strand SE, Berqvist L. Radiolabeled colloids and macromolecules in the lymphatic system. Crit Rev Ther Drug Carrier Syst 1989; 6: 211–38.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, London Health Sciences Center, University of Western Ontario, London, Ontario, Canada

    N. Hodgson MD, C. J. Engel MD, D. Girvan MD & R. Holliday MD

  2. Department of Nuclear Medicine, London Health Sciences Center, University of Western Ontario, London, Ontario, Canada

    P. Zabel MSc & A. G. Mattar MD

  3. London Health Sciences Centre, 375 South St, Victoria Campus, London, Ontario, Canada, N6A 4G5

    R. Holliday MD

Authors
  1. N. Hodgson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Zabel MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. G. Mattar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. J. Engel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Girvan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. Holliday MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Presented at the 53rd Annual Meeting of the Society of Surgical Oncology, New Orleans, Louisiana, March 16–19, 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hodgson, N., Zabel, P., Mattar, A.G. et al. A New Radiocolloid for Sentinel Node Detection in Breast Cancer. Ann Surg Oncol 8, 133–137 (2001). https://doi.org/10.1007/s10434-001-0133-2

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10434-001-0133-2

Key Words

Search

Navigation